Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. NOXXON Pharma N.V.
  6. Summary
    ALNOX   NL0012044762

NOXXON PHARMA N.V.

(ALNOX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
Quotes 5-day view   Real-time Quote. Real-time Euronext Paris
11/22/2021 11/23/2021 11/24/2021 11/25/2021 11/26/2021 Date
0.271(c) 0.286(c) 0.263(c) 0.2776(c) 0.25(c) Last
8 296 371 4 180 907 2 523 594 810 122 1 435 530 Volume
+22.29% +5.54% -8.04% +5.55% -9.94% Change
More quotes
Estimated financial data (e)
Sales 2019 0,15 M 0,17 M 0,17 M
Net income 2019 -0,86 M -0,97 M -0,97 M
Net cash position 2019 1,26 M 1,42 M 1,42 M
P/E ratio 2019 -7,54x
Yield 2019 -
Sales 2020 0,04 M 0,04 M 0,04 M
Net income 2020 -10,4 M -11,8 M -11,8 M
Net cash position 2020 10,2 M 11,5 M 11,5 M
P/E ratio 2020 -1,75x
Yield 2020 -
Capitalization 18,6 M 21,1 M 21,0 M
EV / Sales 2019 41,1x
EV / Sales 2020 405x
Nbr of Employees 12
Free-Float 13,5%
More Financials
Company
NOXXON Pharma NV is a biotechnology company based in the Netherlands that focuses on cancer treatments. The Company's main product is the Spiegelmer platform. Spiegelmers are a variant of a drug class called aptamers, which are based on deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) and are built on a backbone of mirror-image RNA or DNA - L-stereoisomers. The Company's lead candidate, NOX-A12, is under... 
More about the company
All news about NOXXON PHARMA N.V.
11/22NOXXON Pharma N.V. Presents New Phase 1/2 Data On NOX-A12 & Radiotherapy Combination in..
CI
11/22NOXXON : New Phase 1/2 data on NOX-A12 & radiotherapy combination in brain cancer presente..
PU
11/19NOXXON PHARMA N : Presentation by Dr. Frank Giordano at the Society for Neuro-Oncology (SN..
PU
11/17Noxxon to host key opinion leader webinar on nox-a12 and radiotherapy combination, a di..
AQ
11/16NOXXON TO HOST KEY OPINION LEADER WE : a differentiated and promising new approach to trea..
PU
11/15NOXXON PHARMA N : announces convocation of an Extraordinary General Meeting of shareholder..
PU
11/09GLOBAL MARKETS LIVE : Euronext, AMC, PayPal, Roblox, UniCredit...
11/09NOXXON to present at the third edition of Investir Day on November 23 in Paris, France
PU
11/08William Bryan Jennings
PU
11/03NOXXON Provides Update on Timing for Upcoming Trials of NOX-A12 in Pancreatic and Brain..
CI
11/03NOXXON provides update on timing for upcoming trials of NOX-A12 in pancreatic and brain..
PU
10/27NOXXON Pharma N.V. Appoints Bryan Jennings as Chief Financial Officer, Effective Novemb..
CI
10/27Experienced financial executive, Bryan Jennings, joins NOXXON as CFO
PU
10/25GLOBAL MARKETS LIVE : HSBC, PayPal, Tesla, Daimler, Intel...
10/25NOXXON PHARMA N : Reports H1 2021 Financial Results and Provides Business Update
AQ
More news
News in other languages on NOXXON PHARMA N.V.
11/22NOXXON PHARMA : le titre bondit après des données favorables
11/22Les valeurs à suivre aujourd'hui à Paris - Lundi 22 novembre 2021
11/22Coronavirus vs. Black Friday
11/22NOXXON PHARMA N : présente ses données dans le traitement du cancer du cerveau
11/22EN DIRECT DES MARCHES : Vivendi, Ericsson, Telecom Italia, Monster Beverage, Activision Bl..
More news
Chart NOXXON PHARMA N.V.
Duration : Period :
NOXXON Pharma N.V. Technical Analysis Chart | ALNOX | NL0012044762 | MarketScreener
Technical analysis trends NOXXON PHARMA N.V.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Managers and Directors
Aram Andrew Mangasarian Chief Executive Officer & Director
Bryan Jennings Chief Financial Officer
Maurizio PetitBon Chairman-Supervisory Board
Bertram Köhler Member-Supervisory Board
Cornelis Alexander Izeboud Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
NOXXON PHARMA N.V.-55.52%21
MODERNA, INC.215.53%133 648
LONZA GROUP AG29.85%59 443
IQVIA HOLDINGS INC.46.26%50 064
SEAGEN INC.-3.22%30 994
CELLTRION, INC.-40.39%24 431